EPE016	Shaping the implementation science agenda for injectable long-acting cabotegravir for PrEP: results from a workshop convened by the Biomedical Prevention Implementation Collaborative (BioPIC)	E-poster	Implementation science of scaling up prevention (including PrEP)
EPD338	Shared mechanisms underlying elevated risk for HIV and overdose among women who use drugs: a scoping review	E-poster	Conceptualizing social and structural factors and their impacts
EPE175	Shifting from 3-multimonth prescribing (3MMP) to 6-multimonth prescribing (6MMP) was associated with non-inferior outcomes for adults on antiretroviral therapy in Rwanda	E-poster	Differentiated service delivery for HIV testing, prevention and treatment
EPE145	Should a pill a day keep the doctor away? Re-examining assumptions about frequency of sex and continuity of PrEP use	E-poster	Innovations and lessons for supporting HIV prevention effective use and treatment adherence
EPB103	Should HIV control programmes in Africa screen patients with HIV for multi-morbidity: findings from non-communicable diseases screening in the META trial in Dar es Salaam, Tanzania	E-poster	Other non-communicable diseases
PEMOA35	Side-by-side comparison of SARS-CoV-2 neutralizing antibody responses after various COVID-19 vaccine regimens	Poster exhibition	SARS-Cov2 vaccines
EPB095	Silent coronary heart disease in patients on ART: prevalence and risk factors	E-poster	Cardiovascular disease
EPD189	Similarities and differences in men's experience of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) in Southern African high-prevalence settings	E-poster	Other populations vulnerable in specific contexts
PESUB23	Simulations for once weekly dosing of oral lenacapavir	Poster exhibition	Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring
EPA004	Single cell imaging corroborates the link between HIV integration and transcription	E-poster	HIV biology (entry, replicative cycle, transcriptional expression and regulation)